Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03544866 · ClinicalTrials.gov registry record
The Impact of Pediatric Skin Disorders: The "Big" Study
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 1,666
- Enrollment target
NCT03544866 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 1,666 participants.
The verdict
NCT03544866 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 1,666 participants
- Enrollment target
Study Summary
This study leverages the availability of a validated series of instruments to measure the effect of highly visible, chronic skin disorders, including atopic dermatitis (AD), on patients 8 years of age and above in causing stigma and psychiatric issues, particularly anxiety and depression.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,666 participants |
| Start Date | 2018-11-16 |
| Est. Completion | 2022-01-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03544866
The ClinicalTrials.gov registry entry for NCT03544866 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,666 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03544866 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03544866 about?
NCT03544866 is a clinical study titled "The Impact of Pediatric Skin Disorders: The "Big" Study". This study leverages the availability of a validated series of instruments to measure the effect of highly visible, chronic skin disorders, including atopic dermatitis (AD), on patients 8 years of age and above in causing stigma and psychiatric issues, particularly anxiety and depression.
What is the current status of trial NCT03544866?
This trial is currently completed. The enrollment target is 1,666 participants. The study started on 2018-11-16. Estimated completion is 2022-01-31.
Who is sponsoring clinical trial NCT03544866?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.